Cargando…
Late-Onset MS: Disease Course and Safety-Efficacy of DMTS
Multiple sclerosis (MS), an inflammatory demyelinating and neurodegenerative disease of the central nervous system, usually begins between the ages of 20 and 49 years, though in rare cases it is diagnosed in childhood and adolescence before the age of 18 years, or at the age of 50 years and later. W...
Autores principales: | Buscarinu, Maria Chiara, Reniè, Roberta, Morena, Emanuele, Romano, Carmela, Bellucci, Gianmarco, Marrone, Antonio, Bigi, Rachele, Salvetti, Marco, Ristori, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960027/ https://www.ncbi.nlm.nih.gov/pubmed/35356454 http://dx.doi.org/10.3389/fneur.2022.829331 |
Ejemplares similares
-
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
por: Bellucci, Gianmarco, et al.
Publicado: (2021) -
MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases
por: Mechelli, Rosella, et al.
Publicado: (2021) -
Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome
por: Umeton, Renato, et al.
Publicado: (2022) -
A Case of Double Standard: Sex Differences in Multiple Sclerosis Risk Factors
por: Angeloni, Benedetta, et al.
Publicado: (2021) -
CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
por: Rinaldi, Virginia, et al.
Publicado: (2022)